European Markets Poised for Mixed Open as Investors Weigh Fragile USIran Truce PayWhatYouWant Dining Emerges as Restaurants Adapt to Declining Patronage US Consumer Prices Rise 38 in April Exceeding Expectations Highest Since May 2023 Understanding Offer for Sale OFS A Key Mechanism for Shareholders to Exit Maximizing Fuel Savings This Memorial Day Weekend Tips and Market Trends Petrol Diesel CNG Prices Hiked Again Third Increase in 10 Days SRTA Q1 2026 Earnings Surprise Profitability Despite No Reported Revenue LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline PowerFleet AIOT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction TTM Technologies Q1 2026 Earnings EPS Surprises to the Upside Amid Strong Operating Execution Hexcel Corporation HXL Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction The Oncology Institute Inc TOI Q1 2026 Earnings Narrowing Losses Drive Substantial EPS Beat News Corporation Shares Dip 141 as Stock Tests Key Support Levels NWSA T1 Energy Inc TE Faces Sharp Decline as Selling Pressure Intensifies PSQ Holdings Inc PSQH Faces Downward Pressure Near Key Support Genesis Energy LP GEL Slips as Bears Test Key Support Levels Organogenesis Holdings ORGO Holds Steady at 266 Consolidation Phase in Play AMD Plans 10 Billion Investment in Taiwans AI Chip Ecosystem Cadre Holdings Inc CDRE Q1 2026 Earnings EPS Misses Estimates by 417 Amid Revenue Unavailability Silicon Laboratories Inc SLAB Edges Lower Consolidates Near Support at 207 Lovesac LOVE Edges Higher as Stock Holds Above Key Support at 1558 Centessa Pharmaceuticals CNTA Holds Steady Near Key Support After Minimal Movement Shattuck Labs STTK Holds Near Support as Biotech Sentiment Shifts WVVIP Preferred Stock Holds Steady at 267 as Support and Resistance Levels Solidify Radiopharm Theranostics RADX Holds Steady at 449 Consolidation Phase for Radiopharma Play Valneva Shares Edge Higher as Price Action Tests Key Resistance Levels Evergy EVRG Holds Steady Near 84 as Utility Sector Eyes Rate Outlook